{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:24:16Z","timestamp":1788531856478,"version":"build-2803163510"},"reference-count":208,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>MicroRNAs (miRNAs) are evolutionarily conserved, non-coding RNA molecules approximately 18\u201325 nucleotides in length that regulate gene expression at the post-transcriptional level. Their principal mechanism of action is post-transcriptional gene silencing via RNA interference, achieved by binding to complementary sequences within target messenger RNAs (mRNAs). Accumulating evidence has highlighted the pivotal role of miRNAs in the development, differentiation, and function of immune cells, as well as in maintaining immune homeostasis. A more comprehensive understanding of the complex molecular networks governed by these miRNAs may provide valuable insights into disease mechanisms, facilitate clinical decision-making, and ultimately improve patient outcomes. The remarkable stability of miRNAs, together with their presence in the systemic circulation encapsulated within extracellular vesicles, has attracted considerable interest in their clinical application. These characteristics make circulating miRNAs promising candidates as diagnostic biomarkers for the early detection of disease and as prognostic indicators for disease progression and evaluating therapeutic efficacy. Furthermore, an increasing number of miRNA-based studies across diverse immune-related disorders have revealed their potential as therapeutic targets. The integration of synergistic therapeutic strategies and complementary miRNA-based approaches may further enhance treatment efficacy and contribute to the development of novel precision-medicine interventions for immune-related diseases. In this review, we comprehensively discuss the biogenesis and biological functions of miRNAs and examine their regulatory roles in the pathogenesis of rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis, systemic lupus erythematosus (SLE), and atopic dermatitis (AD). We are also evaluating the potential of these miRNAs as diagnostic and prognostic biomarkers, and their promising properties as therapeutic targets in the treatment of immune system-related diseases. These selected diseases represent key immune disorders in which miRNAs serve as strong biomarker candidates for early diagnosis (diagnostic) and disease course (prognostic) due to their stability in systemic circulation and their presence within extracellular vesicles. These six diseases constitute the cluster of \u201cimmune-related disorders,\u201d where miRNA-based studies are steadily increasing, and these molecules hold the highest potential as novel therapeutic targets.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1943071","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:51:22Z","timestamp":1788529882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNAs in immune-related diseases: mechanism, functions and therapeutic perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Tutku","family":"Tun\u00e7","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Sivas Cumhuriyet University","place":["Sivas, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Yaman Ozer","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Trabzon Kanuni Training and Research Hospital, Trabzon University","place":["Trabzon, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Misir","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University","place":["Sivas, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7197931","DOI":"10.1155\/2018\/7197931","article-title":"Immune and inflammatory-mediated disorders: From bench to bedside","volume":"2018","author":"Reale","year":"2018","journal-title":"J Immunol Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1632416","article-title":"Editorial: Innate immune dysregulation: a driving force of autoimmunity and chronic inflammation","volume":"16","author":"Akbarzadeh","year":"2025","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.88327","article-title":"Epigenetic modulations of immune cells: from normal development to tumor progression","volume":"19","author":"Xu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaf039","article-title":"Epigenomic control of immunity: from mechanisms to therapeutic targets in inflammatory bowel diseases","volume":"37","author":"Shih","year":"2025","journal-title":"Int Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18101610","article-title":"miRNA\u2013lncRNA cross-regulation landscape in cancer: from molecular mechanisms to therapeutic and diagnostic applications","volume":"18","author":"Scafuro","year":"2026","journal-title":"Cancers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.70039","article-title":"The power of microRNA regulation-insights into immunity and metabolism","volume":"599","author":"Oliveto","year":"2025","journal-title":"FEBS Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031942","article-title":"Role of microRNAs in immune regulation with translational and clinical applications","volume":"25","author":"Ga\u00e1l","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4110\/in.2011.11.5.227","article-title":"MicroRNAs in human diseases: from autoimmune diseases to skin, psychiatric and neurodegenerative diseases","volume":"11","author":"Ha","year":"2011","journal-title":"Immune Netw"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.593473","article-title":"miRNAs alter T helper 17 cell fate in the pathogenesis of autoimmune diseases","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27104323","article-title":"The mechanistic review of the molecular interface of RNA-loaded extracellular vesicles: redefining targeted therapy for autoimmune disorders","volume":"27","author":"Orassay","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.03.009","article-title":"MicroRNA history: discovery, recent applications, and next frontiers","volume":"717","author":"Almeida","year":"2011","journal-title":"Mutat Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4126106","DOI":"10.1155\/2018\/4126106","article-title":"The involvement of microRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis","volume":"2018","author":"Honarpisheh","year":"2018","journal-title":"J Immunol Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2021.08.003","article-title":"Regulatory roles of microRNA in shaping T cell function, differentiation and polarization","volume":"124","author":"Naqvi","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14062054","article-title":"MicroRNAs in the diagnosis of digestive diseases: a comprehensive review","volume":"14","author":"Popa","year":"2025","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-007-9013-8","article-title":"The microRNA (miRNA): overview of the RNA genes that modulate gene function","volume":"38","author":"Ying","year":"2008","journal-title":"Mol Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-031-64788-8_8","article-title":"MicroRNAs and immune-related disorders","volume-title":"Mirnas, Human Health and Diseases","author":"Abdallah","year":"2024"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.23386","article-title":"Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.05.013","article-title":"A polymorphism in the 3-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility","volume":"77","author":"Chatzikyriakidou","year":"2010","journal-title":"Jt Bone Spine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/ar3006","article-title":"Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis","volume":"12","author":"Li","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0801613","article-title":"Bruton\u2019s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes","volume":"182","author":"Alsaleh","year":"2009","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019827","article-title":"miR-346 controls release of TNF-\u03b1 protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization","volume":"6","author":"Semaan","year":"2011","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.24475","article-title":"MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"60","author":"Nakamachi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.34334","article-title":"Down\u2010regulation of microRNA\u201034a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance","volume":"64","author":"Niederer","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.5907","article-title":"miR-143-3p regulates cell proliferation and apoptosis by targeting IGF1R and IGFBP5 and regulating the Ras\/p38 MAPK signaling pathway in rheumatoid arthritis","volume":"15","author":"Yang","year":"2018","journal-title":"Exp Ther Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1159\/000493222","article-title":"miR-338-5p regulates the viability, proliferation, apoptosis and migration of rheumatoid arthritis fibroblast-like synoviocytes by targeting NFAT5","volume":"49","author":"Guo","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-017-3003-3","article-title":"MicroRNA-192 suppresses cell proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes by downregulating caveolin 1","volume":"432","author":"Li","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.025","article-title":"MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis","volume":"139","author":"Srivastava","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2012.09.004","article-title":"Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions","volume":"148","author":"Xia","year":"2012","journal-title":"Immunol Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1242\/dev.089649","article-title":"Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation","volume":"140","author":"Jackson","year":"2013","journal-title":"Development"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2020.1783934","article-title":"MiR-203 promotes HaCaT cell overproliferation through targeting LXR-a and PPAR-g","volume":"19","author":"Xiao","year":"2020","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.988962","article-title":"Circulating microRNA203 and its target genes' role in psoriasis pathogenesis","volume":"9","author":"Mostafa","year":"2022","journal-title":"Front Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12860-019-0229-9","article-title":"LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21\/caspase-8","volume":"20","author":"Jia","year":"2019","journal-title":"BMC Mol Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120633","article-title":"MicroRNA biomarkers in psoriasis","volume":"29","author":"Singh","year":"2025","journal-title":"Clin Chim Acta"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3892\/br.2018.1146","article-title":"Understanding psoriasis: Role of miRNAs","volume":"9","author":"Timis","year":"2018","journal-title":"BioMed Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202695","article-title":"MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine\/threonine kinase 40","volume":"190","author":"Xu","year":"2013","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2017.7018","article-title":"MiR-99a inhibits keratinocyte proliferation by targeting Frizzled-5 (FZD5) \/ FZD8 through b-catenin signaling in psoriasis","volume":"72","author":"Shen","year":"2017","journal-title":"Pharmazie"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10187","article-title":"MiR-125b-mediated regulation of cell proliferation through the Jagged-1\/Notch signaling pathway by inhibiting BRD4 expression in psoriasis","volume":"19","author":"Pan","year":"2019","journal-title":"Mol Med Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.03.105","article-title":"MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis","volume":"90","author":"Xu","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006309","article-title":"Differential micro RNA expression in PBMC from multiple sclerosis patients","volume":"4","author":"Otaegui","year":"2009","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2023.107873","article-title":"Relationship between miRNA-21, miRNA-155, and miRNA-182 expression and inflammatory factors in cerebrospinal fluid from patients with multiple sclerosis","volume":"232","author":"Shademan","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"B47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molimm.2021.02.008","article-title":"MiRNA-467b inhibits Th17 differentiation by targeting eIF4E in experimental autoimmune encephalomyelitis","volume":"133","author":"Wu","year":"2021","journal-title":"Mol Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/807426","article-title":"MicroRNAs and multiple sclerosis","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Autoimmun Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","volume":"12","author":"Singh","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200940032","article-title":"Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing- remitting multiple sclerosis patients","volume":"40","author":"Lindberg","year":"2010","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904060","article-title":"MicroRNA-21 and microRNA- 148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1","volume":"184","author":"Pan","year":"2010","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2012.10.011","article-title":"MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1","volume":"69","author":"Qin","year":"2013","journal-title":"J Dermatol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/art.30196","article-title":"MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1","volume":"63","author":"Zhao","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B55","article-title":"Expression signature of microRNA-181-areveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus","volume":"29","author":"Lashine","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B56","article-title":"The role of miR-146a in modulating TRAF6-induced inflammation during lupus nephritis","volume":"21","author":"Zheng","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/art.27632","article-title":"MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus","volume":"62","author":"Zhao","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002218","article-title":"Dicer insufficiency and MicroRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu","volume":"186","author":"Divekar","year":"2011","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.840060","article-title":"Deletion of microRNA-183-96-182 cluster in lymphocytes suppresses Anti-DsDNA autoantibody production and IgG deposition in the kidneys in C57BL\/6-Faslpr\/lpr Mice","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307084158","article-title":"Microarray analysis of micro- RNA expression in peripheral blood cells of systemic lupus erythematosus patients","volume":"16","author":"Dai","year":"2007","journal-title":"Lupus"},{"key":"B61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-015-0063-7","article-title":"The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus","volume":"7","author":"Luo","year":"2015","journal-title":"Clin Epigenet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01127","article-title":"Excessive miR-152-3p results in increased BAFF expression in SLE B-cells by inhibiting the KLF5 expression","volume":"10","author":"Luo","year":"2019","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.068","article-title":"MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2\u03b1","volume":"135","author":"Wu","year":"2008","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000436954.70596.9b","article-title":"NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells","volume":"20","author":"Chuang","year":"2014","journal-title":"Inflammation Bowel Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000969","article-title":"Downregulation of MicroRNA-21 in colonic CD3+ T cells in UC remission","volume":"22","author":"Ando","year":"2016","journal-title":"Inflammation Bowel Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.03.122","article-title":"Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB","volume":"434","author":"Yang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/genes9020085","article-title":"MicroRNA-31 and MicroRNA-155 are overexpressed in ulcerative colitis and regulate IL-13 signaling by targeting interleukin 13 receptor \u03b1-1","volume":"9","author":"Gwiggner","year":"2018","journal-title":"Genes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.035","article-title":"The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release","volume":"39","author":"Brain","year":"2013","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.07.005","article-title":"MicroRNA regulation of intestinal epithelial tight junction permeability","volume":"141","author":"Ye","year":"2011","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2017.0019","article-title":"MicroRNA-141 is involved in ulcerative colitis pathogenesis via aiming at CXCL5","volume":"37","author":"Cai","year":"2017","journal-title":"J Interferon Cytokine Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304213","article-title":"miR-141 regulates colonic leukocytic trafficking by targeting CXCL12 during murine colitis and human Crohn\u2019s disease","volume":"63","author":"Huang","year":"2014","journal-title":"Gut"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/path.2907","article-title":"Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis","volume":"225","author":"Bian","year":"2011","journal-title":"J Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cellimm.2017.08.003","article-title":"MicroRNA-124 alleviates chronic skin inflammation in atopic eczema via suppressing innate immune responses in keratinocytes","volume":"319","author":"Yang","year":"2017","journal-title":"Cell Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11010-016-2696-z","article-title":"MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13R\u03b11","volume":"416","author":"Zeng","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13276","article-title":"MiR\u2010151a is involved in the pathogenesis of atopic dermatitis by regulating interleukin\u201012 receptor \u03b22","volume":"27","author":"Chen","year":"2018","journal-title":"Exp Dermatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12624","article-title":"MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 (Th17) cells","volume":"181","author":"Ma","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.02.007","article-title":"Belinostat resolves skin barrier defects in atopic dermatitis by targeting the dysregulated miR-335: SOX6 axis","volume":"146","author":"Liew","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.509","article-title":"Rheumatoid arthritis: pathogenesis and therapeutic advances","volume":"5","author":"Gao","year":"2024","journal-title":"MedComm"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131749","article-title":"Role of miRNAs in rheumatoid arthritis therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Cells"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311060","article-title":"The pathogenesis of rheumatoid arthritis: breakthroughs in molecular mechanisms","volume":"24","author":"Nanke","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2165\/11631480-000000000-00000","article-title":"MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy","volume":"26","author":"Filkov\u00e1","year":"2012","journal-title":"BioDrugs"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.929667","article-title":"The emerging role of circulating microRNAs as biomarkers in autoimmune diseases","volume":"47","author":"Zeng","year":"2014","journal-title":"Autoimmunity"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26209950","article-title":"microRNAs as biomarkers and therapeutic targets in rheumatoid arthritis","volume":"26","author":"Machaj","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2011.02650.x","article-title":"MicroRNAs: emerging regulators of immune\u2010mediated diseases","volume":"75","author":"Tomankova","year":"2012","journal-title":"Scand J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jbspin.2010.06.003","article-title":"MicroRNAs as new player in rheumatoid arthritis","volume":"78","author":"Duroux-Richard","year":"2011","journal-title":"Jt Bone Spine"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.102111","article-title":"IL-10 inhibits miR-155 induction by Toll-like receptors","volume":"285","author":"McCoy","year":"2010","journal-title":"J Biol Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666140825122036","article-title":"Role of synovial fibroblasts in rheumatoid arthritis","volume":"21","author":"Lefevre","year":"2015","journal-title":"Curr Pharm Des"},{"key":"B89","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/ar3013","article-title":"Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis","volume":"12","author":"Murata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069118","article-title":"Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis","volume":"8","author":"Murata","year":"2013","journal-title":"PloS One"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2017.1343545","article-title":"Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis","volume":"74","author":"Abdul-Maksoud","year":"2017","journal-title":"Br J BioMed Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_305_23","article-title":"A study of miRNA 223 expression and its correlation with disease severity in chronic plaque psoriasis","volume":"68","author":"Bantwal","year":"2023","journal-title":"Indian J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.12.008","article-title":"Circulating microRNA associated with TNF-\u03b1 signaling pathway in patients with plaque psoriasis","volume":"61","author":"Oyama","year":"2011","journal-title":"J Dermatol Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2013.2148","article-title":"Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity","volume":"23","author":"Guo","year":"2013","journal-title":"Eur J Dermatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.05.005","article-title":"MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis","volume":"75","author":"L\u00f8vendorf","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513490542","article-title":"Differential microRNA expression in blood in multiple sclerosis","volume":"19","author":"S\u00f8ndergaard","year":"2013","journal-title":"Mult Scler J"},{"key":"B97","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-017-1006-3","article-title":"Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS","volume":"14","author":"Bruinsma","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513485654","article-title":"Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis","volume":"19","author":"Fenoglio","year":"2013","journal-title":"Mult Scler J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516684213","article-title":"miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands","volume":"23","author":"Quintana","year":"2017","journal-title":"Mult Scler J"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2014.04.069","article-title":"miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing\u2013remitting multiple sclerosis","volume":"544","author":"Honardoost","year":"2014","journal-title":"Gene"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182759621","article-title":"Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study","volume":"79","author":"Haghikia","year":"2012","journal-title":"Neurology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000219","article-title":"Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis","volume":"3","author":"Bergman","year":"2016","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3326","article-title":"Circulating miR\u2010181a and miR\u2010223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis","volume":"23","author":"Abdul\u2010Maksoud","year":"2021","journal-title":"J Gene Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clinbiochem.2022.05.004","article-title":"Novel microRNA biomarkers of systemic lupus erythematosus in plasma: miR-124-3p and miR-377-3p","volume":"107","author":"Yan","year":"2022","journal-title":"Clin Biochem"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.10.004","article-title":"Serum miRNA-371b-5p and miRNA-5100 act as biomarkers for systemic lupus erythematosus","volume":"196","author":"Zeng","year":"2018","journal-title":"Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5547635","article-title":"miR\u2010183\u20105p is a potential molecular marker of systemic lupus erythematosus","volume":"2021","author":"Zhou","year":"2021","journal-title":"J Immunol Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell\u2013free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J Rheumatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.152","article-title":"Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity","volume":"27","author":"Lin","year":"2014","journal-title":"Mod Pathol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15159","article-title":"Circulating microRNA146b\u20105p is superior to C\u2010reactive protein as a novel biomarker for monitoring inflammatory bowel disease","volume":"49","author":"Chen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000000430","article-title":"Circulating microRNAs as biomarkers of adult Crohn\u2019s disease","volume":"27","author":"Jensen","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.012","article-title":"Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon","volume":"8","author":"Zahm","year":"2014","journal-title":"J Crohns Colitis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.07.010","article-title":"Plasma miR223 is a possible biomarker for diagnosing patients with severe atopic dermatitis","volume":"70","author":"Yasuike","year":"2021","journal-title":"Allergol Int"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19254","article-title":"MicroRNA analysis of childhood atopic dermatitis reveals a role for miR\u2010451a","volume":"184","author":"Nousbeck","year":"2021","journal-title":"Br J Dermatol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2019.3676","article-title":"Possible role of hsa-miR-194-5p, via regulation of HS3ST2, in the pathogenesis of atopic dermatitis in children","volume":"29","author":"Meng","year":"2019","journal-title":"Eur J Dermatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14871","article-title":"The role of microRNA in psoriasis: a review","volume":"2","author":"Jiang","year":"2023","journal-title":"Exp Dermatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna11010016","article-title":"Psoriasis treatments: emerging roles and future prospects of micrornas","volume":"11","author":"Teo","year":"2025","journal-title":"Non-coding RNA"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14221","article-title":"Insightful exploring of microRNAs in psoriasis and its targeted topical delivery","volume":"33","author":"Pradyuth","year":"2020","journal-title":"Dermatol Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.012","article-title":"miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis","volume":"137","author":"Hermann","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10497.x","article-title":"microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris","volume":"165","author":"Ichihara","year":"2011","journal-title":"Br J Dermatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.294","article-title":"Protein KINASE C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes","volume":"130","author":"Sonkoly","year":"2010","journal-title":"J Investig Dermatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.646796","article-title":"MiRNAs flowing up and down: The concerto of psoriasis","volume":"8","author":"Xiuli","year":"2021","journal-title":"Front Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S493191","article-title":"Expression levels of lncRNA NEAT1, miRNA-21, and IL-17 in a group of Egyptian patients with Beh\u00e7et\u2019s disease: relation to disease manifestations and activity","volume":"18","author":"Hussein","year":"2024","journal-title":"Biol Targets Ther"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2022.100175","article-title":"Targeting TGF-\u03b21\/miR-21 pathway in keratinocytes reveals protective effects of silymarin on imiquimod-induced psoriasis mouse model","volume":"3","author":"Henriet","year":"2023","journal-title":"JID Innov 3"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020916","article-title":"MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R","volume":"6","author":"Lerman","year":"2011","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107467","article-title":"The crosstalk between IL-22 signaling and miR-197 in human keratinocytes","volume":"9","author":"Lerman","year":"2014","journal-title":"PloS One"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042255","article-title":"Multiple sclerosis: roles of miRNA, lcnRNA, and circRNA and their implications in cellular pathways","volume":"25","author":"Cipriano","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.01.020","article-title":"MicroRNA in multiple sclerosis","volume":"516","author":"Gao","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B128","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08830185.2020.1826474","article-title":"The role of microRNAs in multiple sclerosis","volume":"41","author":"Mansoor","year":"2022","journal-title":"Int Rev Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/nri2360","article-title":"WNT signalling in theimmune system: WNT is spreading its wings","volume":"8","author":"Staal","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1768","article-title":"Emerging role of miR-106b-25\/miR-17-92 clusters in the control of transforming growth factor beta signaling","volume":"68","author":"Petrocca","year":"2008","journal-title":"Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.06.009","article-title":"Altered miRNA expression in T regulatory cells in course of multiple sclerosis","volume":"226","author":"De Santis","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12883-022-02909-6","article-title":"Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study","volume":"22","author":"Ali Ashrafi","year":"2022","journal-title":"BMC Neurol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05212-2","article-title":"The circRNA\u2013miRNA\u2013mRNA regulatory network in systemic lupus erythematosus","volume":"40","author":"Zhang","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1059887","article-title":"Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100308","article-title":"Serum andurinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J Rheumatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06534-7","article-title":"Analysis of microRNA-199a-3p expression in CD4+ T cells of systemic lupus erythematosus","volume":"42","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1134634","article-title":"MicroRNA-183\/96\/182 cluster in immunity and autoimmunity","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01234-7","article-title":"MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy","volume":"23","author":"Naithani","year":"2023","journal-title":"Clin Exp Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003336","article-title":"MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus","volume":"9","author":"Deng","year":"2013","journal-title":"PloS Genet"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.11.001","article-title":"MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus","volume":"260","author":"Motawi","year":"2016","journal-title":"Chem Biol Interact"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.7150\/ijbs.74315","article-title":"Dysregulated microRNAs in the pathogenesis of systemic lupus erythematosus: a comprehensive review","volume":"19","author":"Choi","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.7150\/ijbs.59904","article-title":"Roles of microRNAs in inflammatory bowel disease","volume":"17","author":"Jung","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B143","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10238-024-01476-z","article-title":"MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease","volume":"24","author":"Ramadan","year":"2024","journal-title":"Clin Exp Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032233","article-title":"miRNA molecules\u2014late breaking treatment for inflammatory bowel diseases","volume":"24","author":"Aggeletopoulou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147991","article-title":"MicroRNAs as innovative biomarkers for inflammatory bowel disease and prediction of colorectal cancer","volume":"23","author":"Masi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158751","article-title":"MicroRNAs in inflammatory bowel disease and its complications","volume":"23","author":"Krishnachaitanya","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044156","article-title":"Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease","volume":"9","author":"Sohn","year":"2012","journal-title":"PloS One"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.102","article-title":"The signaling axis of microRNA-31\/interleukin-25 regulates Th1\/Th17- mediated inflammation response in colitis","volume":"10","author":"Shi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"4250329","DOI":"10.1155\/2020\/4250329","article-title":"Elevated miRNA inversely correlates with E-cadherin gene expression in tissue biopsies from Crohn disease patients in contrast to ulcerative colitis patients","volume":"2020","author":"Guz","year":"2020","journal-title":"BioMed Res Int"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1042\/CS20140048","article-title":"In Crohn\u2019s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts","volume":"127","author":"Nijhuis","year":"2014","journal-title":"Clin Sci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000298","article-title":"Intestinal fibrosis in Crohn\u2019s disease: Role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets","volume":"21","author":"Lewis","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00268.2017","article-title":"Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease","volume":"314","author":"Soroosh","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.492496","article-title":"NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease","volume":"288","author":"Ghorpade","year":"2013","journal-title":"J Biol Chem"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14392","article-title":"Current understanding of epigenetics in atopic dermatitis","volume":"30","author":"Schmidt","year":"2021","journal-title":"Exp Dermatol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125846","article-title":"The role of microRNA in the pathogenesis of atopic dermatitis","volume":"26","author":"Go\u0142uchowska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119130","article-title":"The essential role of micrornas in inflammatory and autoimmune skin diseases\u2014a review","volume":"24","author":"Dopytalska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/all.13849","article-title":"miR\u201010a\u20105p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation","volume":"74","author":"Vaher","year":"2019","journal-title":"Allergy"},{"key":"B158","article-title":"IFN-\u03b3-induced microRNA-29b up-regulation contributes tokeratinocyte apoptosis in atopic dermatitis through inhibiting Bcl2L2","volume":"10","author":"Gu","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3958453","article-title":"miR\u2010146a attenuates inflammatory pathways mediated by TLR4\/NF\u2010\u03baB and TNF\u03b1 to protect primary human retinal microvascular endothelial cells grown in high glucose","volume":"2016","author":"Ye","year":"2016","journal-title":"Mediat Inflammation"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108983","article-title":"Increased plasma miR-24 and miR-191 levels in patients with severe atopic dermatitis: Possible involvement of platelet activation","volume":"237","author":"Maeno","year":"2022","journal-title":"Clin Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.23736\/s0392-0488.17.05707-8","article-title":"Expression of miRNA 155, FOXP3 and ROR gamma, in children with moderate and severe atopic dermatitis","volume":"155","author":"Bergallo","year":"2017","journal-title":"G Ital Di Dermatol E Venereol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190397","article-title":"The potency of lncRNA MALAT1\/miR-155\/CTLA4 axis in altering Th1\/Th2 balance of asthma","volume":"40","author":"Liang","year":"2020","journal-title":"Biosci Rep"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104452","article-title":"MiR-1294 suppresses ROS-dependent inflammatory response in atopic dermatitis via restraining STAT3\/NF-\u03baB pathway","volume":"371","author":"Yan","year":"2022","journal-title":"Cell Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3390\/cardiogenetics11040023","article-title":"MicroRNAs: from junk RNA to life regulators and their role in cardiovascular disease","volume":"11","author":"Amodio","year":"2021","journal-title":"Cardiogenetics"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102472","article-title":"Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders","volume":"111","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2020","journal-title":"J Autoimmun"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007440","article-title":"Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls","volume":"4","author":"Keller","year":"2009","journal-title":"PloS One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.33588\/rn.6012.2014357","article-title":"MicroRNAs and their neuroimmunoregulator mechanisms in multiple sclerosis. Development of biomarkers for diagnosis","volume":"60","author":"S\u00e1nchez-Chaparro","year":"2015","journal-title":"Rev Neurol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.1038\/s41598-017-14301-3","article-title":"Exosomal microRNA signatures in multiple sclerosis reflect disease status","volume":"7","author":"Ebrahimkhani","year":"2017","journal-title":"Sci Rep"},{"key":"B170","first-page":"71","article-title":"MicroRNA 26a expression in peripheral blood mononuclear cells and correlation with serum interleukin-17 in relapsing-remitting multiple sclerosis patients","volume":"24","author":"Mahmoud","year":"2017","journal-title":"Egypt J Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23880","article-title":"Circulating microRNAs as biomarkers for disease staging in multiple sclerosis","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann Neurol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757096","article-title":"Promising roles of exosomal microRNAs in systemic lupus erythematosus","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0961203310389841","article-title":"Serum and urinary free microRNA level in patients with systemic lupus erythematosus","volume":"20","author":"Wang","year":"2011","journal-title":"Lupus"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2025.102064","article-title":"Circulating and faecal micrornas as non-invasive biomarkers for ibd: current evidence and next steps","volume":"7","author":"Kiudelis","year":"2025","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy046","article-title":"Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases","volume":"24","author":"Sch\u00f6nauen","year":"2018","journal-title":"Inflammation Bowel Dis"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.02.006","article-title":"Circulating MicroRNA in inflammatory bowel disease","volume":"6","author":"Paraskevi","year":"2012","journal-title":"J Crohns Colitis"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12104","article-title":"Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease","volume":"173","author":"Iborra","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000478","article-title":"MicroRNAs classify different disease behavior phenotypes of Crohn\u2019s disease and may have prognostic utility","volume":"21","author":"Peck","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031241","article-title":"Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis","volume":"2","author":"Duttagupta","year":"2012","journal-title":"PloS One"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-015-0069-0","article-title":"MicroRNA signatures differentiate Crohn\u2019s disease from ulcerative colitis","volume":"16","author":"Schaefer","year":"2015","journal-title":"BMC Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10695","article-title":"MicroRNA-146a as a potential regulator involved in the pathogenesis of atopic dermatitis","volume":"20","author":"Yan","year":"2019","journal-title":"Mol Med Rep"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract15110192","article-title":"miRNA-146-a, miRNA-21, miRNA-143, miRNA-29-b and miRNA-223 as Potential Biomarkers for Atopic Dermatitis","volume":"15","author":"Jakovljevic","year":"2025","journal-title":"Clin Pract"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104750","article-title":"The role of microRNAs in inflammatory bowel disease","volume":"26","author":"Sokal-Dembowska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3390\/biom12081072","article-title":"Anti-inflammatory microRNAs for treating inflammatory skin diseases","volume":"12","author":"Yang","year":"2022","journal-title":"Biomolecules"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2026.150081","article-title":"Regulatory roles of microRNAs in epigenetic and immune gene networks in psoriasis","volume":"28","author":"Singh","year":"2026","journal-title":"Gene"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138669","article-title":"miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis","volume":"70","author":"Kawano","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1002\/art.39446","article-title":"Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of microRNAs 140\u20103p and 140\u20105p","volume":"68","author":"Peng","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1608902","article-title":"miRNAs and exosomes in psoriasis: coordinating cytoskeleton dynamics and extracellular matrix remodeling","volume":"13","author":"Li","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13602","article-title":"miRNA\u201031 increases radiosensitivity through targeting STK40 in colorectal cancer cells","volume":"18","author":"Zhang","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"225re1","DOI":"10.1126\/scitranslmed.3008089","article-title":"TargetingmiR-21 to treat psoriasis","volume":"6","author":"Guinea-Viniegra","year":"2014","journal-title":"Sci Transl Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15370","article-title":"miR\u2010205\u20105p inhibits psoriasis\u2010associated proliferation and angiogenesis: Wnt\/\u03b2\u2010catenin and mitogen\u2010activated protein kinase signaling pathway are involved","volume":"47","author":"Xue","year":"2020","journal-title":"J Dermatol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800189","article-title":"miR-340 alleviates psoriasis in micethrough direct targeting of IL-17A","volume":"201","author":"Bian","year":"2018","journal-title":"J Immunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17256","article-title":"Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis","volume":"180","author":"Yan","year":"2019","journal-title":"Br J Dermatol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01256","article-title":"Dysregulated microRNA involvement in multiple sclerosis by induction of T helper 17 cell differentiation","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601727","article-title":"MicroRNA-15b suppresses Th17 differentiation and is associated with pathogenesis of multiple sclerosis by targeting O-GlcNAc transferase","volume":"198","author":"Liu","year":"2017","journal-title":"J Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29624","article-title":"Downregulation of microRNA-101- 3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9","volume":"121","author":"Sun","year":"2020","journal-title":"J Cell Biochem"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13434","article-title":"MicroRNA-590-3p inhibits T helper 17 cells and ameliorates inflammation in lupus mice","volume":"165","author":"Huang","year":"2022","journal-title":"Immunology"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102440","article-title":"Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development","volume":"109","author":"Wang","year":"2020","journal-title":"J Autoimmun"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309389","article-title":"miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-\u03b1 in IBD","volume":"65","author":"He","year":"2016","journal-title":"Gut"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.021","article-title":"Crohn\u2019s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.21","article-title":"MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis","volume":"47","author":"Pathak","year":"2015","journal-title":"Exp Mol Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1089099","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise","year":"2023","journal-title":"Front Med"},{"key":"B203","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13059-016-0901-8","article-title":"Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease","volume":"17","author":"Wang","year":"2016","journal-title":"Genome Biol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2021.20746","article-title":"Protection by microRNA-7a-5p antagomir against intestinal mucosal injury related to the JNK pathway in TNBS-induced experimental colitis","volume":"32","author":"Yin","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103555","article-title":"MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1\u03b1\/TFF-3 axis","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.05.012","article-title":"The role of microRNAs in atopic dermatitis","volume":"9","author":"Khosrojerdi","year":"2024","journal-title":"Non-coding RNA Res"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122656","article-title":"MicroRNAs in several cutaneous autoimmune diseases: psoriasis, cutaneous lupus erythematosus and atopic dermatitis","volume":"9","author":"Domingo","year":"2020","journal-title":"Cells"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.905","article-title":"IL-32\u03b3 suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B","volume":"146","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1943071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:51:26Z","timestamp":1788529886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1943071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":208,"alternative-id":["10.3389\/fimmu.2026.1943071"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1943071","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1943071"}}